Innova Captab

Innova Captab Deferred Tax Liabilities

The Deferred Tax Liabilities of Innova Captab (INNOVACAP.NS) as of Nov 22, 2026 is 131.87 M INR. In the previous year, Deferred Tax Liabilities was 48.42 M INR — a change of 172.35% (higher).

Deferred Tax Liabilities

131.87 MINR

YoY

172.35%

Last updated:

Deferred Tax Liabilities of Innova Captab is 2025 131.87 M INR. Deferred Tax Liabilities of Innova Captab was 2024 48.42 M INR. It decreases by 172.35% higher compared to the previous year.

The Innova Captab Deferred Tax Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Deferred Tax Liabilities
Date
Deferred Tax Liabilities
Jan 1, 2021
19.26 M INR
Jan 1, 2022
20.57 M INR
Jan 1, 2023
39.21 M INR
Jan 1, 2024
48.42 M INR
Jan 1, 2025
131.87 M INR
The Innova Captab Deferred Tax Liabilities history
YEARDeferred Tax LiabilitiesYoY
131.87 MINR+172.35%
48.42 MINR+23.49%
39.21 MINR+90.62%
20.57 MINR+6.80%
19.26 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Innova Captab Stock analysis

What does Innova Captab do? Innova Captab Ltd generates revenue through its CDMO business, which offers research, product development, and manufacturing services to clients in the pharmaceutical sector. The company also earns from its domestic branded generics business, developing, manufacturing, and distributing generic formulation products under its own brand names across India via online and offline channels. Additionally, Innova Captab sells its generic drug products through various e-commerce pharmacy sites. The company's diversified portfolio includes tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. Its international branded generic product business focuses on exporting branded generic products globally. Innova Captab's primary customers are pharmaceutical companies seeking CDMO services, Indian consumers purchasing generic medicines through retail and online pharmacies, and international buyers of branded generic products. The domestic market segment is served through branded generics sold under the company's own brand names, while the international segment targets global markets for branded generic drug exports. The company's value chain spans research and development, manufacturing, drug distribution, marketing, and exports, ensuring comprehensive coverage across the pharmaceutical industry. The company's product segments include CDMO services, domestic branded generics, and international branded generics. CDMO services are provided to pharmaceutical firms requiring outsourced research and manufacturing. Domestic branded generics are marketed in India under the company's brand names through both online and offline channels. International branded generics are exported to global markets, leveraging the company's manufacturing capabilities and product portfolio. Innova Captab's business model integrates all stages of the pharmaceutical value chain, from R&D to exports, to deliver a full-service solution for its clients and customers. Innova Captab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Innova Captab stock

Deferred Tax Liabilities of Innova Captab is 131.87 M INR in 2025.

Deferred Tax Liabilities of Innova Captab changed from 48.42 M INR to 131.87 M INR, representing a 172.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities Innova Captab since 2006 – with annual values, charts, and detailed analysis.

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

Deferred Tax Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's Innova Captab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Innova Captab

All Key Metrics — Innova Captab